Table 1: Clinical course of the patient.
|
No.
of attempt |
OS
methods |
Pre-ovulatory |
Trigger |
Kinds
of treatment |
Pregnancy |
Adverse
effect |
||||||
|
|
|
|
|
follicle
development |
|
|
|
|
|
|
|
|
|
1 |
CC
100 mg/day for 5 days |
Right
side, 18 mm |
HCG
5000IU |
TSIa)
at WDB16 |
no |
mild
OHSS*** |
||||||
|
2 |
CC
100 mg/day for 5 days |
Follicular
growth (-) |
non |
non |
no |
no |
||||||
|
3 |
CC
150 mg/day for 5 days |
Follicular
growth (-) |
non |
non |
no |
no |
||||||
|
4 |
FSH
150 IU/day for 11days |
Total
of 7-8 development follicles |
no |
Severe
OHSS*** |
||||||||
|
Both
sides, 19-18 mm size at WDB13 |
HCG
5000IU |
TSIa)
at WDB15 |
||||||||||
|
5 |
FSH
75 IU/day for 8 days, |
|||||||||||
|
FSH
150 IU/day for 8 days, and |
||||||||||||
|
FSH
300 IU/day for 8 days |
Follicular
growth (-) |
non |
non |
no |
no |
|||||||
|
6 |
Letrozole
25 mg/day for 10 days |
Left
side, 19 mm |
HCG
5000IU |
TSI*
at WDB21 |
no |
no |
||||||
|
7~11 |
Letrozole
25 mg/day plus |
Development
follicles (1–2) |
||||||||||
|
FSH
150 IU/day for 7-8days |
Right
or Left 20–19 mm size |
Gn-RH
agonist |
IUI**
at D14-15 |
no |
no |
|||||||
|
11 |
Letrozole
25 mg/day plus |
Right
side, 21 mm |
Gn-RH
agonist |
IUI**
at D14 |
yes |
no |
||||||
|
|
FSH 150 IU/day for 7 days |
|
|
|
|
|
|
|
|
|
||
a)Timed
sexual intercourse. b) Intrauterine insemination. c) Ovarian hyperstimulation
syndrome.
1)
Ovarian stimulation was started from WDB 5 until third attempt and started from
WDB 3 after fourth attempt.
2) CC,
FSH, and letrozole were administered every day.